DE69029396D1 - Konjugatimpfstoff für gruppe b-streptococcus - Google Patents

Konjugatimpfstoff für gruppe b-streptococcus

Info

Publication number
DE69029396D1
DE69029396D1 DE69029396T DE69029396T DE69029396D1 DE 69029396 D1 DE69029396 D1 DE 69029396D1 DE 69029396 T DE69029396 T DE 69029396T DE 69029396 T DE69029396 T DE 69029396T DE 69029396 D1 DE69029396 D1 DE 69029396D1
Authority
DE
Germany
Prior art keywords
streptococcus
group
conjugate vaccine
vaccine
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69029396T
Other languages
English (en)
Other versions
DE69029396T2 (de
Inventor
James L Michel
Dennis L Kasper
Frederick M Ausubel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
General Hospital Corp
Original Assignee
Brigham and Womens Hospital Inc
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc, General Hospital Corp filed Critical Brigham and Womens Hospital Inc
Application granted granted Critical
Publication of DE69029396D1 publication Critical patent/DE69029396D1/de
Publication of DE69029396T2 publication Critical patent/DE69029396T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69029396T 1989-09-15 1990-09-14 Konjugatimpfstoff für gruppe b-streptococcus Expired - Fee Related DE69029396T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15
PCT/US1990/005251 WO1991004049A1 (en) 1989-09-15 1990-09-14 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS)

Publications (2)

Publication Number Publication Date
DE69029396D1 true DE69029396D1 (de) 1997-01-23
DE69029396T2 DE69029396T2 (de) 1997-06-05

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029396T Expired - Fee Related DE69029396T2 (de) 1989-09-15 1990-09-14 Konjugatimpfstoff für gruppe b-streptococcus

Country Status (22)

Country Link
EP (1) EP0491865B1 (de)
JP (2) JPH05500455A (de)
KR (1) KR0180559B1 (de)
AT (1) ATE146081T1 (de)
AU (1) AU641439B2 (de)
CA (2) CA2383393A1 (de)
DE (1) DE69029396T2 (de)
DK (1) DK0491865T3 (de)
ES (1) ES2097154T3 (de)
FI (1) FI105154B (de)
GR (1) GR1002294B (de)
HU (1) HU219327B (de)
IE (1) IE903349A1 (de)
IL (1) IL95578A (de)
NO (1) NO313908B1 (de)
NZ (1) NZ235316A (de)
PL (3) PL168587B1 (de)
PT (1) PT95316A (de)
RU (1) RU2113234C1 (de)
WO (1) WO1991004049A1 (de)
YU (1) YU176490A (de)
ZA (1) ZA907297B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
IL107103A (en) * 1992-09-24 2001-03-19 Brigham & Womens Hospital A multi-valued vaccine based on an attached molecule containing a capsular polysaccharide attached to a protein and a method for preparing this special molecule
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
CA2158658A1 (en) * 1993-03-19 1994-09-29 Margaretha Stalhammar-Carlemalm Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
AU755343B2 (en) * 1997-12-31 2002-12-12 Montana State University-Bozeman A method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof in a vaccine
CA2591510A1 (en) * 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics, Inc. Group b streptococcus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
EP0302887B1 (de) * 1986-04-16 1994-06-22 The Brigham And Women's Hospital, Inc. Bakterielle antigene, antikörper, impfstoffe und deren herstellung
EP0419462A4 (en) * 1987-07-17 1991-07-17 Xoma Corporation Improved immunotoxin therapies utilizing purified ricin a-chain species

Also Published As

Publication number Publication date
KR920703097A (ko) 1992-12-17
JP2001309795A (ja) 2001-11-06
DE69029396T2 (de) 1997-06-05
GR1002294B (el) 1996-05-03
RU2113234C1 (ru) 1998-06-20
YU176490A (sh) 1992-12-21
AU641439B2 (en) 1993-09-23
JP3447713B2 (ja) 2003-09-16
GR900100692A (el) 1992-01-20
AU6519090A (en) 1991-04-18
NO920942D0 (no) 1992-03-11
DK0491865T3 (da) 1997-06-02
ATE146081T1 (de) 1996-12-15
PL167882B1 (pl) 1995-11-30
NZ235316A (en) 1992-11-25
ZA907297B (en) 1993-06-01
FI921111A0 (fi) 1992-03-13
NO920942L (no) 1992-05-12
EP0491865A1 (de) 1992-07-01
ES2097154T3 (es) 1997-04-01
NO313908B1 (no) 2002-12-23
PT95316A (pt) 1991-06-25
PL286898A1 (en) 1991-06-03
FI105154B (fi) 2000-06-30
IL95578A0 (en) 1991-06-30
HUT63770A (en) 1993-10-28
PL167444B1 (pl) 1995-09-30
KR0180559B1 (ko) 1999-03-20
JPH05500455A (ja) 1993-02-04
HU219327B (en) 2001-03-28
PL168587B1 (pl) 1996-03-29
EP0491865B1 (de) 1996-12-11
WO1991004049A1 (en) 1991-04-04
CA2383393A1 (en) 1991-04-04
CA2066221C (en) 2002-07-23
IL95578A (en) 1998-08-16
IE903349A1 (en) 1991-04-10
CA2066221A1 (en) 1991-03-16
EP0491865A4 (en) 1993-05-05

Similar Documents

Publication Publication Date Title
ATE146081T1 (de) Konjugatimpfstoff für gruppe b-streptococcus
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DE69627149T2 (de) Antigene polysaccharidfragmente mit einer terminalen 2,5-anhydro-d-mannosegruppevon gruppe b-streptococcus, typ ii und typ iii, und daraus hergestellte konjugatimpfstoffe
DK205585D0 (da) Polysaccharidproteinkonjugat, fremgangsmaade til fremstilling deraf ogpraeparat omfattende et polysaccharidproteinkonjugat
IT1262896B (it) Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
BR9406210A (pt) Ensaio de rapamicina
DK0754055T3 (da) Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder
ATE137242T1 (de) Kovalente-ther lipidnukleosid-konjugate
ATE198834T1 (de) Konjugate bestehend aus polysaccharid und protein
DE58901549D1 (de) Hapten-protein-konjugate und ihre verwendung.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
AU7664194A (en) Use of antibodies against beta -2 microglobulin-free, class i hla molecules to provide hiv diagnostic tests as well as compositions having a protective action against hiv infections
DE68922603D1 (de) Makromolekulare konjugate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee